Michael Mühlegger

Marketing Manager

Michael Mühlegger is Marketing Manager.

Articles written by Michael Mühlegger

June 9, 2022

Gene therapy manufacturing - 5 requirements to scale up

Gene therapies have become a highly promising field of groundbreaking next generation treatment, but there are some challenges to face within the manufacturing process. Here are 5 factors that will be crucial for upscaling gene therapy manufacturing with single-use technology.

May 18, 2022

Industry 4.0 in Biomanufacturing: RoSS.KSET as an example

Industry 4.0 has long become reality in many branches. In Pharma 4.0 intelligent industrial applications and IoT enable players in the bioeconomy industry  to transition to operations that help them improve their productivity. Pharma 4.0 also has become a major part in single-use technologies, as it brings companies to the next level concerning the scalability, productivity and efficiency of their processes and products. 

April 4, 2022

Safe transport of single use bags in cell and gene therapies

Cell and Gene therapies such as CAR T-cell therapy have proven their potential to become standard treatments to hard-to-treat diseases. Single Use Support has developed solutions for crucial challenges - read more!

April 4, 2022

Costs for CAR T-cell therapy - How to deploy cost-efficiency

CAR T-cell treatments are deservedly on the rise, as the effectiveness of CAR T-cell products for formerly hard to treat hematology malignancies has been established in clinical trials. This article will highlight one of the less discussed issues of immunotherapy in cancer treatment: it’s current price tag could hamper the broad accessibility to patients.

April 4, 2022

Small batch manufacturing & fill-finish in cell and gene therapy

A great example is the treatment of insidious cancers with CAR T-cells, that relies on modifying the patient’s own T-cells to instill them with a targeted way to fight cancer cells. Learn more why forming strong collaborations will solve many issues!

March 29, 2022

How Pharma 4.0 eliminates human errors in pharmaceutical industry

Pharma 4.0 aims at improving risk management. It aims at updating the pharmaceutical industry and ensuring data integrity by incorporating advanced digital formats and enablers into the current Pharmaceutical Quality System (ICH Q10). The final goal is to minimize, if not eradicate, human error. 

March 21, 2022

Explosive Growth Rate: Single Use Support achieves more than EUR 130 million revenue in 2021

The specialist for pharmaceutical fluid management Single Use Support continues its revenue upwards trend in 2021 with a strong and growing team of close to 150 employees.

March 21, 2022

Interview: Single-Use Systems in Cell and Gene Therapies with Katy Spink, Board Member

Katy Spink is Single Use Support’s newest board member. In order to further grow our expertise in efficient solutions for fluid management and innovative logistic solutions in the cell and gene therapy sector, we asked Katy for her professional insights on topics including the usage and future of single-use systems in the space of cell and gene therapies.

March 21, 2022

Grand opening of Single Use Support’s second location

With the official inauguration of its second site in Hall in Tyrol, the Austrian biopharma fluid management specialist is increasing its capacities of office spaces, warehouse and production of single-use systems threefold.